Burning Rock Biotech Ltd. ADR (BNR): Price and Financial Metrics
BNR Price/Volume Stats
| Current price | $6.58 | 52-week high | $9.99 |
| Prev. close | $6.15 | 52-week low | $2.62 |
| Day low | $5.96 | Volume | 13,700 |
| Day high | $7.00 | Avg. volume | 13,954 |
| 50-day MA | $4.55 | Dividend yield | N/A |
| 200-day MA | $6.07 | Market Cap | 67.41M |
BNR Stock Price Chart Interactive Chart >
Burning Rock Biotech Ltd. ADR (BNR) Company Bio
Burning Rock Biotech Ltd. engages in the investment of medical fields. It specializes in next-generation sequencing diagnostics solutions for precision medicine in oncology. The company operates through following segment: central laboratory business, in-hospital business and pharma research and development services. Its products and clinical applications including companion diagnostics for targeted therapy and immunotherapy, benign, malignant tumor diagnosis, minimal residual disease monitoring, tumor recurrence and progression prediction, and tumor susceptibility tests. Burning Rock Biotech was founded by Yu Sheng Han in 2014 and is headquartered in Guangzhou, China.
BNR Price Returns
| 1-mo | 17.50% |
| 3-mo | 83.80% |
| 6-mo | -3.24% |
| 1-year | -8.62% |
| 3-year | -93.73% |
| 5-year | N/A |
| YTD | -29.25% |
| 2023 | -58.67% |
| 2022 | -76.39% |
| 2021 | -58.74% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...